← All Dossiers
Levels — Series A1
Funded Fund: StoryHouse Fund I  ·  SH Check: $50K  ·  Valuation: $304.7M  ·  Closed: 2022-06-01
Dossier generated 2026-06-03 by /deal-dossier  ·  Deal record: recJnb98YtzSVDbYH  ·  Source: Airtable appjxAR3LPe3fkHOp

One-Liner & Thesis

A wellness platform that leverages biosensors like continuous glucose monitors (CGM) to provide real-time feedback on how diet and lifestyle choices impact metabolic health. The platform tracks blood glucose in real-time, enabling users to optimize their diet and exercise.

Warehoused investment made through through WeFunder SPV. Investment is shown on "pro forma tab of "Levels Health Inc - Series A Pro Forma" Excel spread sheet in the name of Miles Bird (cell P336). In the process of transferring of ownership to SH Funds. SH committed $50K, via StoryHouse Fund I, at a $304.7M valuation, in a $17.1M round, alongside a16z, AH Bio, Loop Ventures, Founder Collective, Trust Ventures.

Deal Box

Round Size
$17.1M
Valuation / Cap
$304.7M
Co-Investors
a16z, AH Bio, Loop Ventures, Founder Collective, Trust Ventures
SH Check
$50K
Fund
StoryHouse Fund I
Funding Round
Series A1
SH Investment Date
2022-06-01

Company Snapshot

Sector
Wellness, Wearables, Healthcare, Digital Health, Fitness
Location
New York, New York
Headcount
24
Year Founded
2019-07-01
Total Raised
$67M
Website
levels.com
Status
Private

Founders

David Flinner
David Flinner at Levels.
Casey Means
Casey Means at Levels.
Josh Clemente
Josh Clemente at Levels.
Andrew Conner
Andrew Conner at Levels.
Sam Corcos
Serial entrepreneur and operator building Levels to advance metabolic health through real-time glucose monitoring and data-driven lifestyle optimization, focused on empowering individuals with continuous health insight.